Benzimidazole-phenoxy-1,2,3-triazole-benzyl Derivatives as the New Potent α-glucosidase Inhibitors: Design, Synthesis, In Vitro, and In Silico Biological Evaluations.

IF 2.5 4区 化学 Q3 CHEMISTRY, ORGANIC
Arash Soltaninejad, Hadi Shirzad, Mohammad Panji, Elahe Motevaseli, Seyyed Amin Mousavinezhad, Saeed Kalbasi
{"title":"Benzimidazole-phenoxy-1,2,3-triazole-benzyl Derivatives as the New Potent α-glucosidase Inhibitors: Design, Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Biological Evaluations.","authors":"Arash Soltaninejad, Hadi Shirzad, Mohammad Panji, Elahe Motevaseli, Seyyed Amin Mousavinezhad, Saeed Kalbasi","doi":"10.2174/0115701794335556241209175911","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>α-Glucosidase inhibitors play an important role in the treatment of type 2 diabetes mellitus. Inhibitors of the latter enzyme that are available on the market created gastrointestinal side effects and achieve to a high potent and low side effect potent α- glucosidase inhibitors is a valuable target for medicinal chemists.</p><p><strong>Objectives: </strong>In this study, derivatives of benzimidazole-phenoxy-1,2,3-triazole-benzyl skeleton were introduced as new α-glucosidase inhibitors.</p><p><strong>Methods: </strong>Twelve derivatives 8a-l of target scaffold were synthesized via simple chemical reactions with a yield between 65 and 88%. The in vitro α-glucosidase inhibition activities of these compounds was evaluated against yeast form of this enzyme. After the determination of most potent compound, the interaction of this compound with α-glucosidase was evaluated in vitro by kinetic study and in silico by docking study. Drug-likeness, pharmacokinetics, and toxicity profiles of the most potent compound were predicted by an online software.</p><p><strong>Results: </strong>Anti-α-glucosidase assay demonstrated that all synthesized derivatives 8a-l were more potent that standard inhibitor acarbose. Representatively, 2-(4-((1-benzyl-1H-1,2,3- triazol-4-yl)methoxy)phenyl)-1H-benzo[d]imidazole (compound 8a) as the most potent derivative was 150-times more potent than positive control. Kinetic study of compound 8a revealed that this compound is an uncompetitive inhibitor against α-glucosidase. Furthermore, molecular docking study showed that compound 8a with favorable binding energy attached to important residues in the α-glucosidase active site. This compound also can be an oral drug with favorable toxicity profile.</p><p><strong>Conclusion: </strong>Benzimidazole-phenoxy-1,2,3-triazole-benzyl derivatives 8a-l synthesized and evaluated for anti-α-glucosidase activity. All these compounds were excellent α-glucosidase inhibitor, and compound 8a demonstrated the most significant inhibition effect when compared with positive control.</p>","PeriodicalId":11101,"journal":{"name":"Current organic synthesis","volume":" ","pages":"721-729"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current organic synthesis","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.2174/0115701794335556241209175911","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0

Abstract

Background: α-Glucosidase inhibitors play an important role in the treatment of type 2 diabetes mellitus. Inhibitors of the latter enzyme that are available on the market created gastrointestinal side effects and achieve to a high potent and low side effect potent α- glucosidase inhibitors is a valuable target for medicinal chemists.

Objectives: In this study, derivatives of benzimidazole-phenoxy-1,2,3-triazole-benzyl skeleton were introduced as new α-glucosidase inhibitors.

Methods: Twelve derivatives 8a-l of target scaffold were synthesized via simple chemical reactions with a yield between 65 and 88%. The in vitro α-glucosidase inhibition activities of these compounds was evaluated against yeast form of this enzyme. After the determination of most potent compound, the interaction of this compound with α-glucosidase was evaluated in vitro by kinetic study and in silico by docking study. Drug-likeness, pharmacokinetics, and toxicity profiles of the most potent compound were predicted by an online software.

Results: Anti-α-glucosidase assay demonstrated that all synthesized derivatives 8a-l were more potent that standard inhibitor acarbose. Representatively, 2-(4-((1-benzyl-1H-1,2,3- triazol-4-yl)methoxy)phenyl)-1H-benzo[d]imidazole (compound 8a) as the most potent derivative was 150-times more potent than positive control. Kinetic study of compound 8a revealed that this compound is an uncompetitive inhibitor against α-glucosidase. Furthermore, molecular docking study showed that compound 8a with favorable binding energy attached to important residues in the α-glucosidase active site. This compound also can be an oral drug with favorable toxicity profile.

Conclusion: Benzimidazole-phenoxy-1,2,3-triazole-benzyl derivatives 8a-l synthesized and evaluated for anti-α-glucosidase activity. All these compounds were excellent α-glucosidase inhibitor, and compound 8a demonstrated the most significant inhibition effect when compared with positive control.

苯并咪唑-苯氧基-1,2,3-三唑-苄基衍生物作为新型有效α-葡萄糖苷酶抑制剂:设计、合成、体外和硅生物学评价
背景:α-葡萄糖苷酶抑制剂在2型糖尿病的治疗中发挥重要作用。市场上的α-葡萄糖苷酶抑制剂对胃肠道产生副作用,而高效低副作用的强效α-葡萄糖苷酶抑制剂是药物化学家研究的一个有价值的靶点。目的:介绍苯并咪唑-苯氧基-1,2,3-三唑-苄基骨架衍生物作为新型α-葡萄糖苷酶抑制剂。方法:通过简单的化学反应合成12个目标支架衍生物8a-l,产率在65 ~ 88%之间。研究了这些化合物对α-葡萄糖苷酶酵母菌的体外抑制活性。在确定最有效的化合物后,通过体外动力学研究和硅对接研究评价该化合物与α-葡萄糖苷酶的相互作用。最有效化合物的药物相似性、药代动力学和毒性谱通过在线软件进行预测。结果:抗α-葡萄糖苷酶实验表明,所有合成的衍生物8a-l的抗α-葡萄糖苷酶活性均高于标准抑制剂阿卡波糖。2-(4-((1-苄基- 1h -1,2,3-三唑-4-基)甲氧基)苯基)- 1h -苯并[d]咪唑(化合物8a)是最有效的衍生物,其效力是阳性对照的150倍。化合物8a的动力学研究表明,该化合物是α-葡萄糖苷酶的非竞争性抑制剂。分子对接研究表明,具有良好结合能的化合物8a附着在α-葡萄糖苷酶活性位点的重要残基上。该化合物也可作为具有良好毒性的口服药物。结论:合成了苯并咪唑-苯氧基-1,2,3-三唑-苄基衍生物8a- 1,并对其抗-α-葡萄糖苷酶活性进行了评价。这些化合物均为优秀的α-葡萄糖苷酶抑制剂,其中化合物8a与阳性对照相比抑制效果最显著。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current organic synthesis
Current organic synthesis 化学-有机化学
CiteScore
3.40
自引率
5.60%
发文量
86
审稿时长
6-12 weeks
期刊介绍: Current Organic Synthesis publishes in-depth reviews, original research articles and letter/short communications on all areas of synthetic organic chemistry i.e. asymmetric synthesis, organometallic chemistry, novel synthetic approaches to complex organic molecules, carbohydrates, polymers, protein chemistry, DNA chemistry, supramolecular chemistry, molecular recognition and new synthetic methods in organic chemistry. The frontier reviews provide the current state of knowledge in these fields and are written by experts who are internationally known for their eminent research contributions. The journal is essential reading to all synthetic organic chemists. Current Organic Synthesis should prove to be of great interest to synthetic chemists in academia and industry who wish to keep abreast with recent developments in key fields of organic synthesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信